Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chubb
Citi
Cerilliant
UBS
Moodys
Federal Trade Commission
Dow
Argus Health
Harvard Business School

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016766

« Back to Dashboard

NDA 016766 describes NORLESTRIN FE 1/50, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the NORLESTRIN FE 1/50 profile page.

The generic ingredient in NORLESTRIN FE 1/50 is ethinyl estradiol; ferrous fumarate; norethindrone acetate. There are twenty-six drug master file entries for this compound. Additional details are available on the ethinyl estradiol; ferrous fumarate; norethindrone acetate profile page.
Summary for 016766
Tradename:NORLESTRIN FE 1/50
Applicant:Parke Davis
Ingredient:ethinyl estradiol; ferrous fumarate; norethindrone acetate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-28Strength0.05MG;75MG;1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Queensland Health
Cantor Fitzgerald
Novartis
Cerilliant
UBS
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot